アブストラクト | AIMS: Adverse drug reactions (ADRs) are known to show sex-specific differences in occurrence and phenotype. The aim of this study was to analyse sex-specific differences in ADR-drug combinations that required hospitalization based on two different datasets. METHODS: We performed a complementary analysis of (i) spontaneously reported (n = 12 564, female = 51.7%) and (ii) systematically collected ADR reports from a prospective multicentre observational study (ADRED, n = 2355, female = 48.2%) from Germany in the ADR database EudraVigilance (EV). Both datasets were analysed separately concerning the suspected drugs, ADRs and ADR-drug combinations more frequently reported for females or males by calculating reporting odds ratios (ROR) with 95% confidence intervals. ADR-drug combinations more frequently reported for either females or males in EV reports were related to prescription data. Finally, the results from both datasets were discussed with regard to their (dis-)concordance. RESULTS: In both datasets, some antineoplastic agents and nervous system drugs were found to be reported more often for females than males (RORs ranging from 1.5 [1.1-2.1] for quetiapine in spontaneous reports to 41.3 [13.1-130.0] for trastuzumab in spontaneous reports). ADRs of the respiratory system, and haemorrhages were described predominantly for males in both datasets. In spontaneous reports the ADR-drug combination self-injurious behaviour-quetiapine was more often reported for females without and with consideration of drug prescriptions (ROR: 3.8 [1.3-11.0]). Quetiapine and psychiatric disorders (superordinate level) was exclusively reported for females in ADRED reports. CONCLUSIONS: Our results can contribute to raise awareness and further knowledge regarding sex-specific ADRs. The findings require further in-depth investigation. |
ジャーナル名 | British journal of clinical pharmacology |
Pubmed追加日 | 2023/10/28 |
投稿者 | Christ, Patrick; Dubrall, Diana; Just, Katja Susanne; Lewke, Britta; Below, Maike; Stingl, Julia Carolin; Schmid, Matthias; Sachs, Bernhardt |
組織名 | Research Division, Federal Institute for Drugs and Medical Devices, Bonn,;Germany.;Institute for Medical Biometry, Informatics and Epidemiology, University Hospital;of Bonn, Bonn, Germany.;Institute of Clinical Pharmacology, University Hospital RWTH Aachen, Aachen,;Central Research Institute for Ambulatory Health Care in Germany, Berlin,;Department for Dermatology and Allergy, University Hospital RWTH Aachen, Aachen, |
Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/37897066/ |